合成路线1
该中间体在本合成路线中的序号:
(II)
【1】
撒应福,任秉钧.2006.头孢类抗生素的制备方法,发明专利申请公开说明书.CN 1763046 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66165 |
sodium (6S,7S)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
C14H14NaN5O6S2 |
详情 | 详情
|
(II) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(III) |
66166 |
(6R,7R)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
C19H25N5O7S2 |
详情 | 详情
|
(IV) |
66167 |
(6S,7S)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
C19H24ClN5O6S2 |
详情 | 详情
|
(V) |
66168 |
(6R,7R)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(iodomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
C19H24IN5O6S2 |
详情 | 详情
|
(VI) |
66169 |
(((6S,7S)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-2-((tert-butoxymethoxy)carbonyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)triphenylphosphonium iodide |
|
C37H39IN5O6S2P |
详情 | 详情
|
(VII) |
66170 |
(6R,7R)-tert-butoxymethyl 7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-3-((triphenylphosphoranylidene)methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, iodide salt |
|
C37H38N5O6S2P |
详情 | 详情
|
(VIII) |
11153 |
4-Methyl-1,3-thiazole-5-carbaldehyde
|
82294-70-0 |
C5H5NOS |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(IX) The reaction of 3-(chloromethyl)-7-(phenylacetamido)-3-cephem-4-carboxylic acid 4-methoxybenzyl ester (I) with triphenylphosphine and NaI in acetone gives the corresponding phosphonium salt (II), which is condensed with 4-methylthiazole-5-carboxaldehyde (III) by means of NaHCO3 in dichloromethane affording 3-[2(Z)-(4-methylthiazol-5-yl)vinyl]-7-(phenylacetamido)-3-cephem-4-carboxylic acid 4-methoxybenzyl ester (IV). The cleavage of the amido group of (IV) with PCl5 and pyridine yields the 7-amino compound (V), which is condensed with 2-(methoxyimino)-2-[2-(tritylamino)thiazol-4-yl]acetic acid (VI) by means of POCl3 in dichloromethane giving 3-[2(Z)-(4-methylthiazol-5-yl)vinyl]-7-[2(Z)-methoxyimino)-2-(2-tritylamino)thiazol-4-yl)acetamido]-3-cephem-4-carboxylic acid 4-methoxybenzyl ester (VII). The deprotection of (VII) with trifluoroacetic acid and anisole yields the free amino acid (VIII), which is finally esterified with iodomethyl pivalate (IX) in DMF.
【1】
Yamamoto, Y.; Yoshida, T.; Tamura, A.; Atsumi, K.; Fukatsu, S.; Sakagami, K.; Nishihata, K.; Synthesis and oral activity of pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3(Z)--(4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylate (ME1207) and its related compound. Chem Pharm Bull 1992, 39, 9, 2433. |
【2】
Atsumi, K.; Sakagami, K.; Yamamoto, Y.; Yoshida, T.; Nishihata, K.; Kondo, S.; Fukatsu, S. (Meiji Seika Kaisha, Ltd.); New cephalosporin cpds. and the production thereof. EP 0175610; ES 8704955; JP 1986178991; JP 1987019593 .
|
【3】
Castaner, J.; Prous, J.; Cefditoren Pivoxil. Drugs Fut 1992, 17, 8, 665.
|
【4】
Sakagami, K.; Tamura, A.; Yoshida, T.; Nishihata, K.; Fukatsu, S.; Atsumi, K.; Synthesis and oral activity of ME1207, a new orally active cephalosporin. J Antibiot 1990, 43, 8, 1047.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11151 |
4-methoxybenzyl (7R)-3-(chloromethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
104146-10-3 |
C24H23ClN2O5S |
详情 | 详情
|
(II) |
11152 |
4-methoxybenzyl (7R)-8-oxo-7-[(2-phenylacetyl)amino]-3-[(triphenylphosphoranyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C42H39N2O5PS |
详情 |
详情
|
(III) |
11153 |
4-Methyl-1,3-thiazole-5-carbaldehyde
|
82294-70-0 |
C5H5NOS |
详情 | 详情
|
(IV) |
11154 |
4-methoxybenzyl (7R)-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C29H27N3O5S2 |
详情 |
详情
|
(V) |
11155 |
4-methoxybenzyl (7R)-7-amino-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C21H21N3O4S2 |
详情 |
详情
|
(VI) |
11156 |
2-(Methoxyimino)-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetamide
|
|
C25H22N4O2S |
详情 |
详情
|
(VII) |
11157 |
4-methoxybenzyl (7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C27H26N6O6S3 |
详情 |
详情
|
(VIII) |
11158 |
(7R)-7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
C19H18N6O5S3 |
详情 |
详情
|
(IX) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(X) Coupling of ethyl glyoxylate derivative (I) with Boc-L-Alanine (II) by means of EDC and DMAP in DMF provides compound (III), whose ethyl ester is subjected to saponification by treatment with NaOH in EtOH to furnish carboxylic acid (IV). Condensation of (IV) with methoxyamine (NH2OMe) in THF/H2O yields methoxyimino acetic acid derivative (V), which is then coupled to pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) in CH2Cl2 by means of phosphorus oxychloride (POCl3) in DMF/EtOAc and N-trimethylsilylacetamide to give compound (VII). Finally, the desired compound is obtained after treatment of (VII) with TFA and anisole in CH2Cl2 for Boc removal . Alternatively, methoxyimino acetic acid derivative (V) can be converted into intermediate (VII) by coupling with 7-amino-3-cephem-4-carboxylic acid (VIII) by means of POCl3 in DMF/EtOAc and N-trimethylsilylacetamide in CH2Cl2 to provide derivative (IX), followed by condensation with iodomethyl pivalate (X) by means of potassium acetate in DMF.
【1】
Muro, H.; Kasai, M.; Hatano, s.; Nishimura, K.-I.; Nishizawa, S.; Kakeya, N. (Kyoto Pharmaceutical Industries, Ltd.); Cephalosporin cpds. and production thereof. EP 0497978; JP 1991204883; US 5389625; WO 9106549 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49506 |
Ethyl 2-amino-4-thiazoleglyoxylate
|
|
C7H8N2O3S |
详情 |
详情
|
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(III) |
49507 |
ethyl 2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-oxoacetate
|
|
C15H21N3O6S |
详情 |
详情
|
(IV) |
49508 |
2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-oxoacetic acid
|
|
C13H17N3O6S |
详情 |
详情
|
(V) |
49509 |
2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetic acid
|
|
C14H20N4O6S |
详情 |
详情
|
(VI) |
49510 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C13H18N2O5S |
详情 |
详情
|
(VII) |
49511 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C27H36N6O10S2 |
详情 |
详情
|
(VIII) |
49512 |
(6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
C7H8N2O3S |
详情 |
详情
|
(IX) |
49513 |
(6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
C21H26N6O8S2 |
详情 |
详情
|
(X) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(X) Coupling of pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) and methoxyimino acetic acid derivative (XI) by means of POCl3 and pyridine in CH2Cl2 gives compound (XII) (alternatively (XII) can be obtained by condensation of ceftizoxime (CZX) (XIII) with iodomethyl pivalate (X) in N,N-dimethylacetamide (DMAc) in the presence of dicyclohexylamine). Coupling of (XII) with Boc-L-alanine (II) by means of EDC and DMAP in CH2Cl2 gives intermediate (VII), whose Boc protecting group is removed by treatment with either HCl/isopropanol in formic acid or TFA and anisole in CH2Cl2.
Yet another strategy can be followed, involving the coupling of pivaloyloxymethyl 7-amino-3-cephem-4-carboxylate (VI) with derivative (XIV) by means of Et3N in N,N-dimethylacetamide.
【1】
Shirahase, H.; Hatano, S.; Yoshimi, A.; Kitagawa, M.; Kasai, M.; Nishimura, K.; Kakeya, N.; AS-924, a novel bifunctional prodrug of ceftizoxime. J Antibiot 1999, 52, 5, 491.
|
【2】
Kasai, M.; et al.; AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicochemical properties and oral absorption. Chem Pharm Bull 1999, 47, 8, 1081.
|
【3】
Muro, H.; Kasai, M.; Hatano, s.; Nishimura, K.-I.; Nishizawa, S.; Kakeya, N. (Kyoto Pharmaceutical Industries, Ltd.); Cephalosporin cpds. and production thereof. EP 0497978; JP 1991204883; US 5389625; WO 9106549 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
26450 |
Boc-L-Alanine;(S)-2-((tert-butoxycarbonyl)amino)propanoic acid;N-Boc-L-alanine; (2S)-2-[(tert-butoxycarbonyl)amino]propionic acid |
15761-38-3 |
C8H15NO4 |
详情 | 详情
|
(VI) |
49510 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C13H18N2O5S |
详情 |
详情
|
(VII) |
49511 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-[2-([(2S)-2-[(tert-butoxycarbonyl)amino]propanoyl]amino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C27H36N6O10S2 |
详情 |
详情
|
(X) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XI) |
24737 |
2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetic acid
|
65872-41-5 |
C6H7N3O3S |
详情 | 详情
|
(XII) |
49514 |
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C19H23N5O7S2 |
详情 |
详情
|
(XIII) |
49515 |
(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
C13H13N5O5S2 |
详情 |
详情
|
(XIV) |
49516 |
2-(2-[[(2S)-2-aminopropanoyl]amino]-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl chloride
|
|
C9H11ClN4O3S |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(VI) Adefovir dipivoxil can be obtained by two similar ways:
1) The reaction of adenine (I) with 2-(diisopropoxyphosphorylmethoxy)ethyl methanesulfonate (II) by means of cesium carbonate in DMF gives the expected condensation product (III), which is converted into the phosphonic acid (IV) by treatment with trimethylsilyl bromide in acetonitrile (1). Finally, this compound is condensed with chloromethyl pivalate (V) by means of N,N'-dicyclohexylmorpholine-4-carboxamidine in DMF.
2) The final condensation of the phosphonic acid (IV) can also be performed with iodomethyl pivalate (VI) in pyridine.
【1】
Benzaria, S.; Pélicano, H.; Johnson, R.; Maury, G.; Imbach, J.-L.; Aubertin, A.-M.; Obert, G.; Gosselin, G.; Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability. J Med Chem 1996, 39, 25, 4958-65. |
【2】
Prous, J.; Graul, A.; Castaner, J.; Adefovir Dipivoxil. Drugs Fut 1997, 22, 8, 825.
|
【3】
Starrett, J.E. Jr.; Mansuri, M.M.; Martin, J.C.; Tortolani, D.R.; Bronson, J.J. (Bristol-Myers Squibb Co.); Prodrug of phosphonates. EP 0481214; JP 1992230694 .
|
【4】
Starrett, J.E. Jr.; Tortolani, D.R.; Russell, J.; Hitchcock, M.J.M.; Whiterock, V.; Martin, J.C.; Mansuri, M.M.; Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA). J Med Chem 1994, 37, 12, 1857-64. |
【5】
Starrett, J.E. Jr.; et al.; Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine. Antivir Res 1992, 19, 3, 267-73.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10343 |
9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine
|
73-24-5 |
C5H5N5 |
详情 | 详情
|
(II) |
16163 |
2-[(diisopropoxyphosphoryl)methoxy]ethyl methanesulfonate
|
|
C10H23O7PS |
详情 |
详情
|
(III) |
16164 |
diisopropyl [2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonate
|
|
C14H24N5O4P |
详情 |
详情
|
(IV) |
16165 |
[2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonic acid
|
|
C8H12N5O4P |
详情 |
详情
|
(V) |
16166 |
chloromethyl pivalate
|
18997-19-8 |
C6H11ClO2 |
详情 | 详情
|
(VI) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(XVIII) Finally, the target compound has been obtained as follows: The selective esterification of the phosphono group of intermediate (IX) with iodomethyl pivalate (XVIII) by means of triethylamine in DMF gives the sulfonic acid (XIX), which was purified through its calcium salt. Finally, this compound is treated with tert-butylamine in methanol to afford the target salt.
【1】
Pendri, Y.; Chen, C.-P.; Kucera, D.J.; Martinez, E.J.; Pansegrau, P.; Thottathil, J.K.; Timmins, P. (Bristol-Myers Squibb Co.); Phosphonosulfonate squalene synthetase inhibitor salts and method. CA 2159850; EP 0710665; JP 1996208672 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IX) |
30173 |
(1S)-4-(3-phenoxyphenyl)-1-phosphono-1-butanesulfonic acid
|
|
C16H19O7PS |
详情 |
详情
|
(XVIII) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XIX) |
30182 |
(1S)-1-(bis[[(2,2-dimethylpropanoyl)oxy]methoxy]phosphoryl)-4-(3-phenoxyphenyl)-1-butanesulfonic acid
|
|
C28H39O11PS |
详情 |
详情
|
(XX) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(IX) 1) The mesylation of 4(S)-hydroxypyrrolidin-2-one (I) with mesyl chloride and triethylamine in pyridine gives the corresponding ester (II), which is treated with potassium thioacetate (III) in refluxing acetonitrile yielding 4(R)-(acetylsulfanyl)pyrrolidin-2-one (IV). The hydrolysis of (IV) with sodium methoxide in methanol followed by acidification with aqueous HCl affords 4(R)-sulfanylpyrrolidin-2-one (V), which is condensed with (1R,5S,6S)-2-(diphenoxyphosphoryloxy)-6-[1(R)-hydroxyethyl]-1-methyl-1-carba-2-penem-3-carboxylic acid p-nitrobenzyl ester (VI) by means of ethyldiisopropylamine in acetonitrile to give (1R,5S,6S)-6-[1(R)-hydroxyethyl]-1-methyl-2-[5-oxopyrrolidin-3(R)-ylsulfanyl]-1-carba-2-penem-3-carboxylic acid p-nitrobenzyl ester (VII). The hydrogenolysis of (VII) with H2 over Pd/C in THF/aqueous phosphate buffer yields the sodium salt (VIII), which is finally esterified with pivaloyloxymethyl iodide (IX) in dimethylacetamide.
【1】
Yasuda, H.; Kuwahara, S.; Kawamoto, I.; Miyauchi, M.; Endo, R.; Hisaoka, M.; CS-834, a new oral carbapenem: I. Structure-activity relationships of 2-substituted 1beta-methylcarbapenems. 36th Intersci Conf Antimicrob Agents Chemother (Sept 15-18, New Orleans) 1996, Abst F105. |
【2】
Endo, R.; Yasuda, H.; Kawamoto, I.; Hisaoka, M.; Miyauchi, M.; Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834. J Antibiot 1997, 50, 5, 429-39.
|
【3】
Graul, A.; Castañer, R.M.; Castañer, J.; Leeson, P.; CS-834. Drugs Fut 1998, 23, 3, 261. |
【4】
Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 . |
【5】
Kawamoto, I.; Miyauchi, M.; Endo, R. (Sankyo Co., Ltd.); Crystalline carbapenem deriv. EP 0599512; JP 1995165759 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17188 |
(S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone
|
68108-18-9 |
C4H7NO2 |
详情 | 详情
|
(II) |
17189 |
(3S)-5-oxotetrahydro-1H-pyrrol-3-yl methanesulfonate
|
|
C5H9NO4S |
详情 |
详情
|
(III) |
17190 |
potassium ethanethioate
|
10387-40-3 |
C2H3KOS |
详情 | 详情
|
(IV) |
17191 |
S-[(3R)-5-oxotetrahydro-1H-pyrrol-3-yl] ethanethioate
|
|
C6H9NO2S |
详情 |
详情
|
(V) |
17192 |
(4R)-4-sulfanyltetrahydro-2H-pyrrol-2-one
|
157429-42-0 |
C4H7NOS |
详情 | 详情
|
(VI) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(VII) |
17194 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-oxotetrahydro-1H-pyrrol-3-yl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C21H23N3O7S |
详情 |
详情
|
(VIII) |
17195 |
sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3R)-5-oxopyrrolidinyl]sulfanyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C14H17N2NaO5S |
详情 |
详情
|
(IX) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(XII) A short-step synthesis of CS-834 has been described:
The condensation of azetidinone (I) with pyrrolidinone (II) by means of CDI gives the thioester (III), which is desilylated with BF3/Et2O to the alcohol (IV). In order to have a more labile protecting group, alcohol (IV) is resilylated with TMS-Cl (or TES-Cl) and triethylamine affording the silyl ether (V), which is protected again at the pyrrolidine nitrogen with TES-Cl, affording the disilylated azetidinone (VI). The condensation of (VI) with the oxalyl chloride (VII) by means of triethylamine in dichloromethane gives the expected oxalylazetidinone (VIII), which is treated with diethyl ethylphosphonite in toluene yielding the ylide (IX). This compound, without isolation, is cyclized in refluxing mesitylene to afford the protected carbapenem intermediate (X), which is finally desilylated with HCl in acetonitrile. The cyclization of azetidinone (VIII) to carbapenem (X) can also be performed with triethyl phosphite instead of diethyl ethylphosphonite. The oxalyl chloride (VII) is obtained by monoesterification of oxalic acid (XI) with pivaloyloxymethyl iodide (XII) by means of triethylamine yielding monoester (XIII), which is finally converted to intermediate (VII) by treatment with oxalyl chloride in dichloromethane.
【1】
Oida, S.; Mori, M.; A short-step synthesis of orally active carbapenem antibiotic CS-834. Chem Pharm Bull 2000, 48, 1, 126.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30029 |
(2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propionic acid
|
|
C14H27NO4Si |
详情 |
详情
|
(II) |
17192 |
(4R)-4-sulfanyltetrahydro-2H-pyrrol-2-one
|
157429-42-0 |
C4H7NOS |
详情 | 详情
|
(III) |
33402 |
S-[(3R)-5-oxopyrrolidinyl] (2R)-2-[(2S,3S)-3-((1R)-1-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-4-oxoazetidinyl]propanethioate
|
|
C18H32N2O4SSi |
详情 |
详情
|
(IV) |
33403 |
S-[(3R)-5-oxopyrrolidinyl] (2R)-2-[(2S,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidinyl]propanethioate
|
|
C12H18N2O4S |
详情 |
详情
|
(V) |
33404 |
S-[(3R)-5-oxopyrrolidinyl] (2R)-2-((2S,3S)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)propanethioate
|
|
C15H26N2O4SSi |
详情 |
详情
|
(VI) |
33405 |
S-[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl] (2R)-2-((2S,3S)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)propanethioate
|
|
C21H40N2O4SSi2 |
详情 |
详情
|
(VII) |
17199 |
[(2-chloro-2-oxoacetyl)oxy]methyl pivalate
|
|
C8H11ClO5 |
详情 |
详情
|
(VIII) |
33406 |
[[2-((2S,3S)-2-((1R)-1-methyl-2-oxo-2-[[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl]sulfanyl]ethyl)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)-2-oxoacetyl]oxy]methyl pivalate
|
|
C29H50N2O9SSi2 |
详情 |
详情
|
(IX) |
33407 |
[[2-[diethoxy(ethyl)phosphoranylidene]-2-((2S,3S)-2-((1R)-1-methyl-2-oxo-2-[[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl]sulfanyl]ethyl)-4-oxo-3-[(1R)-1-[(trimethylsilyl)oxy]ethyl]azetidinyl)acetyl]oxy]methyl pivalate
|
|
C35H65N2O10PSSi2 |
详情 |
详情
|
(X) |
33408 |
[(2,2-dimethylpropanoyl)oxy]methyl (4R,5S,6S)-4-methyl-7-oxo-3-[[(3R)-5-oxo-1-(triethylsilyl)pyrrolidinyl]sulfanyl]-6-[(1R)-1-[(trimethylsilyl)oxy]ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C29H50N2O7SSi2 |
详情 |
详情
|
(XI) |
15713 |
Oxalic acid
|
144-62-7 |
C2H2O4 |
详情 | 详情
|
(XII) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XIII) |
33409 |
2-[[(2,2-dimethylpropanoyl)oxy]methoxy]-2-oxoacetic acid
|
|
C8H12O6 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(XIXa) Condensation of (phosphoryloxy)carbapenem (XVI) with 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine (XI) gave thioether (XVII). The p-nitrobenzyl ester group of (XVII) was then deprotected with Zn powder to afford carboxylic acid. Finally, treatment of (XVIII) with either iodo or chloromethyl pivalate (XIX) produced the target compound.
【1】
Satoh, C.; Mihira, A.; Yamamoto, S.; Hayashi, K.; Kitamura, M.; Tamai, S.; Abe, T.; Kumagai, T.; Hikida, M.; L-084, a new oral carbapenem: Synthesis and structure-activity relationships of C2-substituted 1beta-methylcarbapenems. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-64. |
【2】
Abe, T.; Isoda, T.; Sato, C.; Mihira, A.; Tamai, S.; Kumagai, T. (Lederle (Japan), Ltd.); 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivs.. EP 0632039; EP 0717042; JP 1996053453; US 5534510; US 5659043; US 5783703 .
|
【3】
Abe, T.; Kumagai, T. (Lederle (Japan), Ltd.); Carbapenem-3-carboxylic acid ester derivs.. EP 0808315; JP 1999504039; US 5886172; WO 9721712 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIXa) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XIXb) |
16166 |
chloromethyl pivalate
|
18997-19-8 |
C6H11ClO2 |
详情 | 详情
|
(XI) |
31404 |
1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinylhydrosulfide; 1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinethiol
|
179337-57-6 |
C6H10N2S2 |
详情 | 详情
|
(XVI) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(XVII) |
31408 |
4-nitrobenzyl (4R,5S,6S)-3-[[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C23H26N4O6S2 |
详情 |
详情
|
(XVIII) |
31409 |
(4R,5S,6S)-3-[[1-(4,5-dihydro-1,3-thiazol-2-yl)-3-azetidinyl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
|
C16H21N3O4S2 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(X) Protection of alcohol (I) with TBDMSCl and imidazole gives silyl compound (II) which is N-methylated by means of NaH and MeI and then deprotected with HCl to yield derivative (III). Mesylation of (III) with MsCl in presence of Et3N followed by thioacetylation with AcSK (A) affords thioacetate (IV) which is then hydrolyzed with NaOMe to yield (V). Treatment of (VI) with diphenylphosphoryl chloride (B) and DIEA in acetonitrile yields (VII), which is then condensed with mercaptan (V) by means of DIEA in the same solvent to provide carbapenem (VIII). Deprotection of the carboxyl moiety of (VIII) by hydrogenation with H2 over Pd/C affords carboxylate (IX), which is finally esterified with pivaloyloxymethyl iodide (X) in N,N-dimethylacetamide or DMF.
【1】
Miyauchi, M.; Ohya, S.; Kawamoto, I.; Shibayama, T.; Kanno, O.; Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. J Antibiot 1999, 52, 10, 900.
|
【2】
Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
16074 |
Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate
|
2524-64-3 |
C12H10ClO3P |
详情 | 详情
|
(A) |
17190 |
potassium ethanethioate
|
10387-40-3 |
C2H3KOS |
详情 | 详情
|
(I) |
17188 |
(S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone
|
68108-18-9 |
C4H7NO2 |
详情 | 详情
|
(II) |
41640 |
(4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-pyrrolidinone
|
|
C10H21NO2Si |
详情 |
详情
|
(III) |
41641 |
(4S)-4-hydroxy-1-methyl-2-pyrrolidinone
|
|
C5H9NO2 |
详情 |
详情
|
(IV) |
41642 |
S-[(3R)-1-methyl-5-oxopyrrolidinyl] ethanethioate
|
|
C7H11NO2S |
详情 |
详情
|
(V) |
41643 |
(4R)-1-methyl-4-sulfanyl-2-pyrrolidinone
|
|
C5H9NOS |
详情 |
详情
|
(VI) |
37720 |
4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(VII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(VIII) |
41644 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3R)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C22H25N3O7S |
详情 |
详情
|
(IX) |
41645 |
sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3R)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C15H19N2NaO5S |
详情 |
详情
|
(X) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(XI) Alcohol (I) is protected with TBDMSCl and imidazole to give silyl compound (II), which is N-methylated by means of NaH and MeI and then deprotected with HCl to yield derivative (III). Mitsunobu reaction of (III) with 4-nitrobenzoic acid in presence of PPh3 and DEAD, followed by ester hydrolysis with K2CO3, provides alcohol (IV). Mesylation of (IV) with MsCl in presence of Et3N, followed by thioacetylation with AcSK (A), affords thioacetate (V), which is then hydrolyzed with NaOMe to yield (VI). Treatment of (VII) with diphenylphosphoryl chloride (B) in CH3CN and DIEA in CH3CN yields (VIII), which is then condensed with mercaptan (VI) by means of DIEA in the same solvent to provide carbapenem (IX). Deprotection of the carboxyl moiety of (IX) by hydrogenation with H2 over Pd/C affords carboxylate (X), which is finally esterified with pivaloyloxymethyl iodide (XI) in N,N-dimethylacetamide or DMF.
【1】
Miyauchi, M.; Ohya, S.; Kawamoto, I.; Shibayama, T.; Kanno, O.; Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety. J Antibiot 1999, 52, 10, 900.
|
【2】
Kawamoto, I.; Tanaka, T.; Endo, R.; Miyauchi, M.; Iwata, M. (Sankyo Co., Ltd.); 2-(Heterocyclylthio)carbapenem derivs. their preparation and their use as antibiotics. AU 8932386; EP 0337637; EP 0597821; JP 1990028180; JP 1990049783; US 5104867; US 5242914 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
16074 |
Diphenyl phosphoryl chloride; 1,1'-Diphenylphosphoryl chloride; Chlorodiphenyl Phosphate; Diphenyl chlorophosphate; Diphenylchlorophosphate
|
2524-64-3 |
C12H10ClO3P |
详情 | 详情
|
(A) |
17190 |
potassium ethanethioate
|
10387-40-3 |
C2H3KOS |
详情 | 详情
|
(I) |
17188 |
(S)-4-hydroxy-2-pyrrolidone; (4S)-4-hydroxytetrahydro-2H-pyrrol-2-one; (S)-4-hydroxypyrrolidone
|
68108-18-9 |
C4H7NO2 |
详情 | 详情
|
(II) |
41640 |
(4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-pyrrolidinone
|
|
C10H21NO2Si |
详情 |
详情
|
(III) |
41641 |
(4S)-4-hydroxy-1-methyl-2-pyrrolidinone
|
|
C5H9NO2 |
详情 |
详情
|
(IV) |
41648 |
(4R)-4-hydroxy-1-methyl-2-pyrrolidinone
|
|
C5H9NO2 |
详情 |
详情
|
(V) |
41649 |
S-[(3S)-1-methyl-5-oxopyrrolidinyl] ethanethioate
|
|
C7H11NO2S |
详情 |
详情
|
(VI) |
41650 |
(4S)-1-methyl-4-sulfanyl-2-pyrrolidinone
|
|
C5H9NOS |
详情 |
详情
|
(VII) |
37720 |
4-nitrobenzyl (4R,5R,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(VIII) |
13224 |
4-nitrobenzyl (4R,5R,6S)-3-[(diphenoxyphosphoryl)oxy]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
90776-59-3 |
C29H27N2O10P |
详情 | 详情
|
(IX) |
41646 |
4-nitrobenzyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3S)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C22H25N3O7S |
详情 |
详情
|
(X) |
41647 |
sodium (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-3-[[(3S)-1-methyl-5-oxopyrrolidinyl]sulfanyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C15H19N2NaO5S |
详情 |
详情
|
(XI) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XV) Alkylation of 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol (I) with ethyl bromide in the presence of K2CO3 afforded the ethoxy derivative (II). Subsequent oxidation of (II) with sodium dichromate and H2SO4 provided the desired ketone (III) along with minor amounts of the isomeric 7-oxo compound (IV) that were separated by column chromatography. Conversion of (III) to the corresponding oxime (V), followed by reduction with aluminum amalgam yielded amine (VI). Resolution was achieved via formation of the diastereomeric amides with (R)-alpha-methoxyphenylacetyl chloride (VII) and isolation of the desired isomer (VIII) by preparative HPLC. Cleavage of amide and ether groups of (VIII) by means of HBr furnished (R)-4-amino-3-hydroxy-4,5,6,7-tetrahydro-1,2-benzisoxazole (IX). Protection as the corresponding tert-butyl carbamate, followed by N-methylation with CH3I and NaH provided intermediate (X). An alternative procedure for the preparation of intermediate (X) consisted in the reductive amination of ketone (III) with methylamine and NaBH3CN, followed by condensation of the resulting amine (XI) with the chiral acid chloride (VII) and chromatographic isolation of the desired diastereoisomer (XII). The alpha-methoxyphenylacetyl group of (XII) was then removed by an alternative method consisting in the treatment with lithium triethylborohydride to give the chiral amine (XIII). Cleavage of the ethyl ether group of (XIII) was effected by means of HBr in AcOH, and the resulting compound (XIV) was condensed with di-tert-butyl dicarbonate to produce carbamate (X). Subsequent reaction of (X) with pivaloyloxymethyl iodide (XV) in the presence of potassium tert-butoxide yielded the target O-alkylated compound (XVI) along with some N-alkylated regioisomer. The Boc protecting group of (XVI) was finally removed by treatment with trifluoroacetic acid.
【1】
Frolund, B.; Falch, E.; Perregaard, J.; et al.; Selective inhibitors of glial GABA uptake: Synthesis, absolute stereochemistry, and pharmacology of the enantiomers of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and analogues. J Med Chem 1999, 42, 26, 5402. |
【2】
Falch, E.; Moltzen, L.S.; Schousboe, A.; Frolund, B.; Perregaard, J.K.; Krogsgaard-Larsen, P. (H. Lundbeck A/S); 4-Aminotetrahydrobenzisoxazole or -isothiazole cpds.. WO 9626929 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11021 |
Methanamine; Methylamine
|
74-89-5 |
CH5N |
详情 | 详情
|
(I) |
37236 |
4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol
|
|
C7H9NO2 |
详情 |
详情
|
(II) |
37237 |
ethyl 4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl ether; 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazole
|
|
C9H13NO2 |
详情 |
详情
|
(III) |
37238 |
3-ethoxy-6,7-dihydro-1,2-benzisoxazol-4(5H)-one
|
|
C9H11NO3 |
详情 |
详情
|
(IV) |
37239 |
3-ethoxy-5,6-dihydro-1,2-benzisoxazol-7(4H)-one
|
|
C9H11NO3 |
详情 |
详情
|
(V) |
37240 |
3-ethoxy-6,7-dihydro-1,2-benzisoxazol-4(5H)-one oxime
|
|
C9H12N2O3 |
详情 |
详情
|
(VI) |
37241 |
3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine; 3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-ylamine
|
|
C9H14N2O2 |
详情 |
详情
|
(VII) |
16302 |
(2R)-2-methoxy-2-phenylethanoyl chloride
|
|
C9H9ClO2 |
详情 |
详情
|
(VIII) |
37242 |
(2R)-N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-2-methoxy-2-phenylethanamide
|
|
C18H22N2O4 |
详情 |
详情
|
(IX) |
37243 |
(4R)-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol
|
|
C7H10N2O2 |
详情 |
详情
|
(X) |
34244 |
methyl 2-[(1R,2R,3R)-2-[(benzyloxy)methyl]-5-[(Z)-2-methoxy-2-oxoethylidene]-3-[(tetrahydro-2H-pyran-2-yloxy)methyl]cyclopentyl]acetate
|
|
C25H34O7 |
详情 |
详情
|
(XI) |
37245 |
N-(3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl)-N-methylamine; 3-ethoxy-N-methyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine
|
|
C10H16N2O2 |
详情 |
详情
|
(XII) |
37246 |
(2R)-N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-2-methoxy-N-methyl-2-phenylethanamide
|
|
C19H24N2O4 |
详情 |
详情
|
(XIII) |
37247 |
(4R)-3-ethoxy-N-methyl-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-amine; N-[(4R)-3-ethoxy-4,5,6,7-tetrahydro-1,2-benzisoxazol-4-yl]-N-methylamine
|
|
C10H16N2O2 |
详情 |
详情
|
(XIV) |
37248 |
(4R)-4-(methylamino)-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-ol
|
|
C8H12N2O2 |
详情 |
详情
|
(XV) |
11159 |
iodomethyl pivalate
|
|
C6H11IO2 |
详情 |
详情
|
(XVI) |
37249 |
([(4R)-4-[(tert-butoxycarbonyl)(methyl)amino]-4,5,6,7-tetrahydro-1,2-benzisoxazol-3-yl]oxy)methyl pivalate
|
|
C19H30N2O6 |
详情 |
详情
|